Document:

Form of Note for the Company's 4.450% Subordinated Notes due September 29, 2027

 Exhibit 4.01 

FORM OF NOTE FOR THE COMPANY’S 4.450% SUBORDINATED NOTES DUE 

SEPTEMBER 29, 2027 
 This
Subordinated Note is a Global Security within the meaning of the Indenture hereinafter referred to and is registered in the name of the Depository named below or a nominee of the Depository. This Subordinated Note is not exchangeable for
Subordinated Notes registered in the name of a Person other than the Depository or its nominee except in the limited circumstances described herein and in the Indenture, and no transfer of this Subordinated Note (other than a transfer of this
Subordinated Note as a whole by the Depository to a nominee of the Depository or by a nominee of the Depository to the Depository or another nominee of the Depository) may be registered except in the limited circumstances described herein. 

Unless this certificate is presented by an authorized representative of The Depository Trust Company, a New York corporation (the
“Depository”), to Citigroup Inc. or its agent for registration of transfer, exchange, or payment, and any certificate issued in respect thereof is registered in the name of Cede & Co. or in such other name as is requested by an
authorized representative of the Depository (and any payment is made to Cede & Co. or to such other entity as is requested by an authorized representative of the Depository), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE
BY OR TO ANY PERSON IS WRONGFUL inasmuch as the registered owner hereof, Cede & Co., has an interest herein. 
 The
Subordinated Notes are not savings accounts or deposits but are unsecured obligations of Citigroup Inc. The Subordinated Notes are not insured by the Federal Deposit Insurance Corporation or by any other federal agency or instrumentality. 

CITIGROUP INC. 
 4.450%
Subordinated Notes due September 29, 2027 
  

			
	REGISTERED	  	REGISTERED
		
		  	CUSIP: 172967KA8
		  	ISIN: US172967KA87
		  	Common Code: 129965223
		
	No. R-000[    ]	  	$500,000,000

 CITIGROUP INC., a Delaware corporation (the “Company”, which term includes any successor Person
under the Indenture), for value received, hereby promises to pay to Cede & Co., or registered assigns, the principal sum of $500,000,000 on September 29, 2027 and to pay interest thereon from and including September 29, 2015 or
from the most recent Interest Payment Date (as defined herein) to which interest has been paid or duly provided for, semi-annually, on March 29 and September 29 of each year, commencing March 29, 2016, at the rate of 4.450% per
annum, until the principal hereof is paid or made available for payment (each such payment date, an “Interest Payment Date”). The Subordinated Notes may be redeemed in whole, 

 
but not in part, at any time if changes involving United States taxation occur which could require Citigroup to pay additional amounts. 

The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as provided in the Indenture, be paid
pursuant to the instructions of the Person in whose name this Subordinated Note is registered at the close of business on the Record Date for such interest, which shall be the Business Day immediately preceding such Interest Payment Date. 

Any such interest not so punctually paid or duly provided for will forthwith cease to be payable to the holder on such Record Date and may
either be paid pursuant to the instructions of the Person in whose name this Subordinated Note is registered at the close of business on a subsequent Record Date, such subsequent Record Date to be not less than five days prior to the date of payment
of such defaulted interest, notice whereof shall be given to holders of Subordinated Notes of this series not less than 15 days prior to such subsequent Record Date, or be paid at any time in any other lawful manner not inconsistent with the
requirements of any securities exchange on which the Subordinated Notes of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in the Indenture. 

Interest hereon will be calculated on the basis of a 360-day year comprised of twelve 30-day months or, in the case of an incomplete month,
the number of days elapsed. In the event the Subordinated Notes do not continue to remain in book-entry only form, Citigroup shall have the right to select record dates, which shall be more than 14 days but less than 60 days prior to an Interest
Payment Date. 
 If an Interest Payment Date falls on a day that is not a Business Day, such Interest Payment Date will be the next
succeeding Business Day. If the Maturity of the Subordinated Notes falls on a day that is not a Business Day, the payment due on Maturity will be postponed to the next succeeding Business Day, and no further interest will accrue in respect of such
postponement. If a date for payment of interest or principal on the Subordinated Notes falls on a day that is not a business day in the place of payment, such payment will be made on the next succeeding business day in such place of payment as if
made on the date the payment was due. No interest will accrue on any amounts payable for the period from and after the due date for payment of such principal or interest. 

For these purposes, “Business Day” means any day on which commercial banks settle payments and are open for general business in The
City of New York. 
 Payment of the principal of and interest on this Subordinated Note will be made at the office or agency of the Trustee
maintained for that purpose in The City of New York. 
 Reference is hereby made to the further provisions of this Subordinated Note set
forth on the reverse hereof, which further provisions shall for all purposes have the same effect as if set forth at this place. 

  
 2 

 Unless the certificate of authentication hereon has been executed by the Trustee or by an
authenticating agent on behalf of the Trustee by manual signature, this Subordinated Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 

  
 3 

 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed under its
corporate seal. 
 Dated: September 29, 2015 
  

			
	CITIGROUP INC.
		
	By:	 	  

	Title:  Deputy Treasurer

  

			
	ATTEST:
		
	By:	 	  

	Title: Assistant Secretary

  
 4 

 This is one of the Notes of the series issued under the within-mentioned Indenture. 

Dated: September 29, 2015 
  

			
	 THE BANK OF NEW YORK MELLON,
 as
Trustee

		
	By:	 	  

		 	Name:
		 	Title:
	
	-or-
	
	 CITIBANK, N.A.,
 as Authenticating
Agent

		
	By:	 	  

		 	Name:
		 	Title:

  
 5 

 This Subordinated Note is one of a duly authorized issue of Securities of the Company (the
“Subordinated Notes”), issued and to be issued in one or more series under the Indenture, dated as of April 12, 2001, as supplemented August 2, 2004 (as so supplemented, the “Indenture”), between the Company and The
Bank of New York Mellon (successor to J.P. Morgan Trust Company, N.A. and Bank One Trust Company, N.A.), as Trustee (the “Trustee”, which term includes any successor trustee under the Indenture), to which Indenture and all indentures
supplemental thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee and the holders of the Subordinated Notes and of the terms upon which the
Subordinated Notes are, and are to be, authenticated and delivered. This Subordinated Note is one of the series designated on the face hereof, initially limited in aggregate principal to $2,000,000,000. 

The Company covenants and agrees that the indebtedness evidenced by the Subordinated Notes is subordinate and junior in right of payment to
all Senior Indebtedness (as defined in the Indenture) to the extent provided in the Indenture, and each holder of Subordinated Notes, by his or her acceptance thereof, likewise covenants and agrees to the subordination provided in the Indenture
(including Article Fourteen thereof) and shall be bound by the provisions thereof. 
 In the event that the Company shall default in the
payment of any principal of (or premium, if any) or interest on any Senior Indebtedness when the same becomes due and payable after any applicable grace period, whether at maturity or at a date fixed for prepayment or by declaration or otherwise,
then, unless and until such default shall have been cured or waived or shall have ceased to exist, no direct or indirect payment (in cash, property, securities, by set-off or otherwise) shall be made or agreed to be made on account of the principal
of, or premium, if any, or interest on the indebtedness evidenced by the Subordinated Notes, or in respect of any redemption, retirement or other acquisition of any of the Subordinated Notes, except that holders of Subordinated Notes may receive and
retain (x) securities of the Company or any other corporation provided for by a plan of reorganization or readjustment the payment of which is subordinate, at least to the extent provided in these subordination provisions with respect to the
indebtedness evidenced by the Subordinated Notes, to the payment of all Senior Indebtedness at the time outstanding and to any securities issued in respect thereof under any such plan of reorganization or readjustment and (y) payments made from
a defeasance trust created pursuant to Article Eleven of the Indenture. 
 In the event of: 

(i) any insolvency, bankruptcy, receivership, liquidation, reorganization, readjustment, composition or other similar proceeding relating to
the Company, its creditors or its property, 
 (ii) any proceeding for liquidation, dissolution or other winding up of the Company,
voluntary or involuntary, whether or not involving insolvency or bankruptcy proceedings, 
 (iii) any assignment by the Company for the
benefit of creditors, or 

  
 6 

 (iv) any other marshalling of the assets of the Company, 

all Senior Indebtedness (including any interest thereon accruing after the commencement of any such proceedings) shall first be paid in full before any
payment or distribution, whether in cash, securities or other property, shall be made to any Holder of any of the Subordinated Notes on account thereof (except as provided in the next sentence). Any payment or distribution, whether in cash,
securities or other property (other than (x) securities of the Company or any other corporation provided for by a plan of reorganization or readjustment the payment of which is subordinate, at least to the extent provided in these subordination
provisions with respect to the indebtedness evidenced by the Subordinated Notes, to the payment of all Senior Indebtedness at the time outstanding and to any securities issued in respect thereof under any such plan of reorganization or readjustment
and (y) payments made from a defeasance trust created pursuant to Article Eleven of the Indenture), which would otherwise (but for these subordination provisions) be payable or deliverable in respect of the Subordinated Notes shall be paid or
delivered directly to the holders of Senior Indebtedness in accordance with the priorities then existing among such holders until all Senior Indebtedness (including any interest thereon accruing after the commencement of any such proceedings) shall
have been paid in full. 
 If an event of default (as defined in the Indenture) with respect to Subordinated Notes of this series shall
occur and be continuing, the principal of the Subordinated Notes of this series may be declared due and payable in the manner and with the effect provided in the Indenture. 

The Indenture contains provisions for defeasance at any time of the entire indebtedness of this Subordinated Note upon compliance by the
Company with certain conditions set forth in Article Eleven thereof, which provisions apply to this Subordinated Note. 
 The Indenture
contains provisions permitting the Company and the Trustee, without the consent of the holders of Securities, to establish, among other things, the form and terms of any series of Securities issuable thereunder by one or more supplemental
indentures, and, with the consent of the holders of not less than a majority of the principal amount of Securities at the time Outstanding which are affected thereby, to modify the Indenture or any supplemental indenture or the rights of the holders
of Securities of such series to be affected, provided that no such modification shall, without the consent of the holder of each Outstanding Security so affected, (x) change the Stated Maturity of the principal of, or any installment of
principal of or interest on, any Security, or reduce the principal amount thereof or the rate of interest thereon or any premium thereon, or change any place of payment where, or the coin or currency in which any Security or any premium or interest
thereon is payable, or impair the right to institute suit for the enforcement of any such payment on or after the Stated Maturity thereof (or, in the case of redemption on or after the Redemption Date) or modify the provisions of the Indenture with
respect to the subordination of the Securities in a manner adverse to the Securityholders or (y) reduce the aforesaid percentage in principal amount of the Outstanding Securities of any series, the consent of the holders of which is required
for any supplemental indenture, or the consent of whose holders is required for any waiver provided for in the Indenture, or (z) modify certain other provisions of the Indenture, as set forth in Section 13.02 of the Indenture. 

  
 7 

 No reference herein to the Indenture and no provision of this Subordinated Note or of the
Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of and interest on this Subordinated Note at the times, place and rate, and in the coin or currency, herein prescribed. 

This Subordinated Note is a Global Security registered in the name of a nominee of the Depository. This Subordinated Note is exchangeable for
Subordinated Notes registered in the name of a person other than the Depository or its nominee only in the limited circumstances hereinafter described. Unless and until it is exchanged in whole or in part for definitive Subordinated Notes in
certificated form, this Subordinated Note may not be transferred except as a whole by the Depository to a nominee of the Depository or by a nominee of the Depository to the Depository or another nominee of the Depository. 

The Subordinated Notes represented by this Global Security are exchangeable for definitive Subordinated Notes in certificated form of like
tenor as such Subordinated Notes in denominations of $1,000 and whole multiples of $1,000 in excess thereof only if (i) the Depository notifies the Company that it is unwilling or unable to continue as Depository for the Subordinated Notes or
(ii) the Depository ceases to be a clearing agency registered under the Securities Exchange Act of 1934, as amended, or (iii) the Company in its sole discretion decides to allow the Subordinated Notes to be exchanged for definitive
Subordinated Notes in registered form. Any Subordinated Notes that are exchangeable pursuant to the preceding sentence are exchangeable for certificated Subordinated Notes issuable in authorized denominations and registered in such names as the
Depository shall direct. As provided in the Indenture and subject to certain limitations therein set forth, the transfer of definitive Subordinated Notes in certificated form is registrable in the register maintained by the Company in The City of
New York for such purpose, upon surrender of the definitive Subordinated Note for registration of transfer at the office or agency of the registrar, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the
Company and the registrar duly executed by, the holder thereof or his attorney duly authorized in writing, and thereupon one or more new Subordinated Notes of this series and of like tenor, of authorized denominations and for the same aggregate
principal amount, will be issued to the designated transferee or transferees. Subject to the foregoing, this Subordinated Note is not exchangeable, except for a Global Security or Global Securities of this issue of the same principal amount to be
registered in the name of the Depository or its nominee. 
 No service charge shall be made for any such registration of transfer or
exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 

Prior to due presentment of this Subordinated Note for registration of transfer, the Company, the Trustee and any agent of the Company or the
Trustee may treat the Person in whose name this Subordinated Note is registered as the owner hereof for all purposes, whether or not this Subordinated Note be overdue, and neither the Company, the Trustee nor any such agent shall be affected by
notice to the contrary. 

  
 8 

 The Company will pay additional amounts (“Additional Amounts”) to the beneficial owner
of any Subordinated Note that is a non-United States person in order to ensure that every net payment on such Subordinated Note will not be less, due to payment of U.S. withholding tax, than the amount then
due and payable. For this purpose, a “net payment” on a Subordinated Note means a payment by the Company or a paying agent, including payment of principal and interest, after deduction for any present or future tax, assessment or other
governmental charge of the United States. These Additional Amounts will constitute additional interest on the Subordinated Note. 
 The
Company will not be required to pay Additional Amounts, however, in any of the circumstances described in items (1) through (13) below. 
  

	 	(1)	Additional Amounts will not be payable if a payment on a Subordinated Note is reduced as a result of any tax, assessment or other governmental charge that is imposed or withheld solely by reason of the beneficial owner:

  

	 	(a)	having a relationship with the United States as a citizen, resident or otherwise; 

  

	 	(b)	having had such a relationship in the past or 

  

	 	(c)	being considered as having had such a relationship. 

  

	 	(2)	Additional Amounts will not be payable if a payment on a Subordinated Note is reduced as a result of any tax, assessment or other governmental charge that is imposed or withheld solely by reason of the beneficial owner:

  

	 	(a)	being treated as present in or engaged in a trade or business in the United States; 

  

	 	(b)	being treated as having been present in or engaged in a trade or business in the United States in the past or 

  

	 	(c)	having or having had a permanent establishment in the United States. 

  

	 	(3)	Additional Amounts will not be payable if a payment on a Subordinated Note is reduced as a result of any tax, assessment or other governmental charge that is imposed or withheld in whole or in part by reason of the
beneficial owner being or having been any of the following (as such terms are defined in the Internal Revenue Code of 1986, as amended): 

  

	 	(a)	personal holding company; 

  

	 	(b)	foreign personal holding company; 

  

	 	(c)	foreign private foundation or other foreign tax-exempt organization; 

  

	 	(d)	passive foreign investment company; 

  

	 	(e)	controlled foreign corporation or 

  

	 	(f)	corporation which has accumulated earnings to avoid United States federal income tax. 

  

	 	(4)	 Additional Amounts will not be payable if a payment on a Subordinated Note is reduced as a result of any tax, assessment or other governmental charge
that is 

  
 9 

	 	
imposed or withheld solely by reason of the beneficial owner owning or having owned, actually or constructively, 10 percent or more of the total combined voting power of all classes of stock of
the Company entitled to vote or by reason of the beneficial owner being a bank that has invested in a Subordinated Note as an extension of credit in the ordinary course of its trade or business. 

For purposes of items (1) through (4) above, “beneficial owner” means a fiduciary, settlor, beneficiary, member or shareholder of the
holder if the holder is an estate, trust, partnership, limited liability company, corporation or other entity, or a person holding a power over an estate or trust administered by a fiduciary holder. 

 

	 	(5)	Additional Amounts will not be payable to any beneficial owner of a Subordinated Note that is a: 

  

	 	(a)	fiduciary; 

  

	 	(b)	partnership; 

  

	 	(c)	limited liability company or 

  

	 	(d)	other fiscally transparent entity 

 or that is not the sole beneficial owner of the Subordinated
Note, or any portion of the Subordinated Note. However, this exception to the obligation to pay Additional Amounts will only apply to the extent that a beneficiary or settlor in relation to the fiduciary, or a beneficial owner or member of the
partnership, limited liability company or other fiscally transparent entity, would not have been entitled to the payment of an Additional Amount had the beneficiary, settlor, beneficial owner or member received directly its beneficial or
distributive share of the payment. 
  

	 	(6)	Additional Amounts will not be payable if a payment on a Subordinated Note is reduced as a result of any tax, assessment or other governmental charge that is imposed or withheld solely by reason of the failure of the
beneficial owner or any other person to comply with applicable certification, identification, documentation or other information reporting requirements. This exception to the obligation to pay Additional Amounts will only apply if compliance with
such reporting requirements is required by statute or regulation of the United States or by an applicable income tax treaty to which the United States is a party as a precondition to exemption from such tax, assessment or other governmental charge.

  

	 	(7)	Additional Amounts will not be payable if a payment on a Subordinated Note is reduced as a result of any tax, assessment or other governmental charge that is collected or imposed by any method other than by withholding
from a payment on a Subordinated Note by the Company or a paying agent. 

  

	 	(8)	 Additional Amounts will not be payable if a payment on a Subordinated Note is reduced as a result of any tax, assessment or other governmental charge
that is imposed or withheld by reason of a change in law, regulation, or administrative or 

  
 10 

	 	
judicial interpretation that becomes effective more than 15 days after the payment becomes due or is duly provided for, whichever occurs later. 

 

	 	(9)	Additional Amounts will not be payable if a payment on a Subordinated Note is reduced as a result of any tax, assessment or other governmental charge that is imposed or withheld by reason of the presentation by the
beneficial owner of a Subordinated Note for payment more than 30 days after the date on which such payment becomes due or is duly provided for, whichever occurs later. 

 

	 	(10)	Additional Amounts will not be payable if a payment on a Subordinated Note is reduced as a result of any: 

  

	 	(a)	estate tax; 

  

	 	(b)	inheritance tax; 

  

	 	(c)	gift tax; 

  

	 	(d)	sales tax; 

  

	 	(e)	excise tax; 

  

	 	(f)	transfer tax; 

  

	 	(g)	wealth tax; 

  

	 	(h)	personal property tax or 

  

	 	(i)	any similar tax, assessment, withholding, deduction or other governmental charge. 

  

	 	(11)	Additional Amounts will not be payable if a payment on a Subordinated Note is reduced as a result of any tax, assessment, or other governmental charge required to be withheld by any paying agent from a payment of
principal or interest on a Subordinated Note if such payment can be made without such withholding by any other paying agent. 

  

	 	(12)	Additional amounts will not be payable if a payment on a Subordinated Note is reduced as a result of any tax, assessment or other governmental charge that is required to be made pursuant to any European Union directive
on the taxation of savings income or any law implementing or complying with, or introduced to conform to, any such directive. 

  

	 	(13)	 Additional amounts will not be payable if a payment on a Subordinated Note is reduced as a result of any withholding, deduction, tax, duty assessment
or other governmental charge that would not have been imposed but for a failure by the holder or beneficial owner of a Subordinated Note (or any financial institution through which the holder or beneficial owner holds the Subordinated Note or
through which payment on the Subordinated Note is made) to take any action (including entering into an agreement with the Internal Revenue Service, or a governmental authority of another jurisdiction if the holder is entitled to the benefits of an
intergovernmental agreement between that jurisdiction and the United States) or to comply with any applicable certification, documentation, information or other reporting requirement or agreement concerning accounts maintained by the holder

  
 11 

	 	
or beneficial owner (or any such financial institution), or concerning ownership of the holder or beneficial owner, or any substantially similar requirement or agreement. 

 

	 	(14)	Additional Amounts will not be payable if a payment on a Subordinated Note is reduced as a result of any combination of items (1) through (14) above. 

Except as specifically provided herein, the Company will not be required to make any payment of any tax, assessment or other governmental
charge imposed by any government or a political subdivision or taxing authority of such government. 
 As used in this Subordinated Note,
“United States person” means: 
  

	 	(a)	any individual who is a citizen or resident of the United States; 

  

	 	(b)	any corporation, partnership or other entity created or organized in or under the laws of the United States; 

  

	 	(c)	any estate if the income of such estate falls within the federal income tax jurisdiction of the United States regardless of the source of such income and 

 

	 	(d)	any trust if a United States court is able to exercise primary supervision over its administration and one or more United States persons have the authority to control all of the substantial decisions of the trust.

 Additionally, “non-United States person” means a person who is not a
United States person, and “United States” means the states of the United States of America and the District of Columbia, but excluding its territories and its possessions. 

Except as provided below, the Subordinated Notes may not be redeemed prior to maturity. 

 

	 	(1)	The Company may, at its option, redeem the Subordinated Notes if: 

  

	 	(a)	the Company becomes or will become obligated to pay Additional Amounts as described above; 

  

	 	(b)	the obligation to pay Additional Amounts arises as a result of any change in the laws, regulations or rulings of the United States, or an official position regarding the application or interpretation of such laws,
regulations or rulings, which change is announced or becomes effective on or after September 23, 2015 and 

  

	 	(c)	the Company determines, in its business judgment, that the obligation to pay such Additional Amounts cannot be avoided by the use of reasonable measures available to it, other than substituting the obligor under the
Subordinated Notes or taking any action that would entail a material cost to the Company. 

  

	 	(2)	The Company may also redeem the Subordinated Notes, at its option, if: 

  
 12 

	 	(a)	any act is taken by a taxing authority of the United States on or after September 23, 2015, whether or not such act is taken in relation to the Company or any affiliate, that results in a substantial probability
that the Company will or may be required to pay Additional Amounts as described above; 

  

	 	(b)	the Company determines, in its business judgment, that the obligation to pay such Additional Amounts cannot be avoided by the use of reasonable measures available to it, other than substituting the obligor under the
Subordinated Notes or taking any action that would entail a material cost to the Company and 

  

	 	(c)	the Company receives an opinion of independent counsel to the effect that an act taken by a taxing authority of the United States results in a substantial probability that the Company will or may be required to pay the
Additional Amounts described above, and delivers to the Trustee a certificate, signed by a duly authorized officer, stating that based on such opinion the Company is entitled to redeem the Subordinated Notes pursuant to their terms.

 Any redemption of the Subordinated Notes as set forth in clauses (1) or (2) above shall be in whole, and not in part, and will be
made at a redemption price equal to 100% of the principal amount of the Subordinated Notes Outstanding plus accrued interest thereon to the date of redemption. Holders shall be given not less than 30 days nor more than 60 days’ prior notice by
the Trustee of the date fixed for such redemption. 
 All terms used in this Subordinated Note which are defined in the Indenture shall have
the meanings assigned to them in the Indenture. The Subordinated Notes are governed by the laws of the State of New York. 

  
 13Exhibit
10.1

 

Employment
Agreement

 

This
Employment Agreement (this “Agreement”), dated as of October 27, 2015 (the “Effective Date”),
is made by and between Lindblad Expeditions Holdings, Inc., a Delaware corporation (together with any successor thereto, the “Company”)
and John T. McClain (“Executive”) (collectively Executive and the Company are referred to herein
as the “Parties”).

 

RECITALS

 

		A.	It
                                         is the desire of the Company to assure itself of the services of Executive effective
                                         as of the Effective Date (as defined below) and thereafter by entering into this Agreement.

 

		B.	Executive
                                         and the Company mutually desire that Executive provide services to the Company on the
                                         terms herein provided.

 

AGREEMENT

 

NOW,
THEREFORE, in consideration of the foregoing and of the respective covenants and agreements set forth below, the Parties hereto
agree as follows:

 

	1.	Employment.

 

(a)          General.
Effective as of the Effective Date, the Company shall employ Executive for the period and in the position set forth in this Section
1, and subject to the other terms and conditions herein provided.

 

(b)          Employment
Term. The term of employment under this Agreement (the “Term”) shall be for the period beginning on the
Executive’s first day of active employment with the Company (the “Effective Date”), and ending on the fourth
anniversary thereof, subject to earlier termination as provided in Section 3. The Term shall automatically renew for additional
twelve (12) month periods unless no later than sixty (60) days prior to the end of the applicable Term either Party gives written
notice of non-renewal to the other, in which case Executive’s employment will terminate
at the end of the then-applicable Term, subject to earlier termination as provided in Section 3.

 

(c)          Position
and Duties. Executive shall serve as the Chief Financial Officer of the Company, with such responsibilities, duties and authority
normally associated with such position and such additional responsibilities, duties and authority as may from time to time be
assigned to Executive by the Chief Executive Officer of the Company or by the Board of Directors of the Company or an authorized
committee thereof (in any case, the “Board”). Executive shall report directly to the Chief Executive Officer
of the Company. Executive shall devote substantially all of Executive’s working time and efforts to the business and affairs
of the Company (which shall include service to its subsidiaries) and shall not engage in outside business activities without the
consent of the Board, provided that Executive shall be permitted to (i) manage Executive’s personal, financial
and legal affairs, (ii) participate in charitable, religious, civic, community, industry or trade organizations or associations,
(iii) serve on the board of directors of not-for-profit or tax-exempt organizations and (iv) with the prior approval
of the Board (not to be unreasonably withheld), serve on the board of directors and the committees thereof of not more than two
(2) public corporations, provided that approval for Executive’s continued service on the boards of directors and committees
thereof of Lands’ End, Inc. and Seritage is deemed granted hereby, in each case, subject to compliance with this Agreement
and provided that such activities do not materially interfere with Executive’s performance of Executive’s duties
and responsibilities hereunder. Executive agrees to observe and comply with the rules and policies of the Company applicable to
executive officers as adopted by the Company from time to time, in each case as amended from time to time, as set forth in writing,
and as delivered or made available to Executive (each, a “Policy”).

 

     

     

    

 

	2.	Compensation and Related Matters.

 

(a)          Annual
Base Salary. During the Term, Executive shall receive a base salary at a rate of $425,000 per annum, which shall be paid in
accordance with the customary payroll practices of the Company and its subsidiaries (but in no event less frequently than semi-monthly)
and shall be pro-rated for partial years of employment. Such annual base salary shall be reviewed (and may be adjusted upwards)
from time to time by the Board or the Compensation Committee of the Board (the “Compensation Committee”) (such
annual base salary, as it may be adjusted upwards from time to time, the “Annual Base Salary”). All amounts
paid to Executive under this Agreement shall be in U.S. dollars.

 

(b)          Bonus.
During the Term and beginning with calendar year 2015, Executive will be eligible to participate in an annual incentive program
established by the Board or the Compensation Committee. Executive’s annual compensation under such incentive program (the
“Annual Bonus”) shall be targeted at 75% of his Annual Base Salary (the “Target Bonus”).
The Annual Bonus will scale upward and downward based on individual and/or actual Company performance, as determined by the Board
or the Compensation Committee. The payment of any Annual Bonus pursuant to the incentive program shall be subject to any applicable
performance determinations as may be made annually by the Board or the Compensation Committee, and Executive’s continued
employment with the Company through the date of payment, except as otherwise provided in Section 4(b) or Section 4(c).
The Annual Bonus, if any, shall be paid to Executive no later than seventy five (75) days following the end of the calendar year
to which the Annual Bonus relates. Any Annual Bonus earned for calendar year 2015 shall be prorated to reflect the partial year
of service.

 

(c)          Equity
Compensation. On the Effective Date, Executive will be granted an option (the “Option”) to purchase 300,000
shares of the Company’s common stock, pursuant to the terms of the Company’s 2015 Long-Term Incentive Plan (the “Plan”)
and a separate stock option agreement that will be entered into with Executive. The Option shall have a ten year term, vest in
equal installments on the first four anniversaries of the Effective Date, and shall not be subject to any performance-based or
other conditions (except as set forth in the Plan or the stock option agreement). The per share exercise price of the Option will
be equal to the closing price of the common stock on the NASDAQ Stock Market on the Effective Date. In addition, during the Term,
Executive will be eligible to participate in and may receive additional awards under any of the Company’s equity incentive
award plans and programs as in effect from time to time, with any new equity incentive grants made in the sole discretion of the
Board or Compensation Committee and with the expectation that Executive will receive an annual equity incentive grant under such
equity incentive award plans or programs of the Company. The grant date fair value of Executive’s annual equity incentive
grant shall be targeted at 100% of his Annual Base Salary, it being understood that all equity incentive grants are made in the
sole discretion of the Board or Compensation Committee and may vary year-to-year based on benchmarking, performance or other considerations
as may be determined by the Board or Compensation Committee in its discretion. In the event that the first annual equity incentive
grant for the Company’s executives generally occurs prior to the first anniversary of the Effective Date, the grant date
fair value of Executive’s equity incentive grant shall be prorated to reflect the partial year of service.

 

(d)          Benefits.
During the Term, Executive shall be eligible to participate in employee benefit plans, programs and arrangements (including perquisite
and fringe benefit arrangements) maintained for senior executives of the Company (including, effective on the Effective Date,
medical, dental, life insurance, disability, paid time off and 401(k) plans), consistent with the terms thereof, on a basis consistent
with the participation of senior executives of the Company, and as such plans, programs and arrangements may be amended from time
to time. In no event shall Executive be eligible to participate in any severance plan or program of the Company, except as set
forth in Section 4 of this Agreement.

 

    	 	2	 

     

    

 

(e)          Vacation.
During the Term, Executive shall be entitled to a minimum of twenty (20) days annually of paid vacation in accordance with the
Company’s Policies.

 

(f)          Business
Expenses. The Company shall reimburse Executive for all reasonable travel and other business expenses incurred by Executive
in the performance of Executive’s duties to the Company in accordance with the Company’s expense reimbursement Policy
and in compliance with Section 12(m).

 

	3.	Termination.

 

Executive’s
employment hereunder may be terminated by the Company or Executive, as applicable, without any breach of this Agreement under
the following circumstances:

 

	 	(a)	Circumstances.

 

(i)          Death.
Executive’s employment hereunder shall terminate upon Executive’s death.

 

(ii)         Disability.
If Executive has incurred a Disability, as defined below, the Company may terminate Executive’s employment.

 

(iii)        Termination
for Cause. The Company may terminate Executive’s employment for Cause, as defined below.

 

(iv)        Termination
without Cause. The Company may terminate Executive’s employment without Cause, which shall include a termination of
Executive as a result of the Company not renewing the Term pursuant to Section 1.

 

(v)         Resignation
from the Company for Good Reason. Executive may resign Executive’s employment with the Company for Good Reason, as defined
below.

 

(vi)        Resignation
from the Company Without Good Reason. Executive may resign Executive’s employment with the Company for any reason, other
than Good Reason, or for no reason, which shall include a termination of Executive as a result of Executive not renewing the Term
pursuant to Section 1.

 

(b)          Notice
of Termination. Any termination of Executive’s employment by the Company or by Executive under this Section 3
(other than termination pursuant to Section 3(a)(i)) shall be communicated by a written notice to the other Party (i) indicating
the specific termination provision in this Agreement relied upon, (ii) setting forth in reasonable detail the facts and circumstances
claimed to provide a basis for termination of Executive’s employment under the provision so indicated, if applicable, and
(iii) specifying a Date of Termination which, except in the case of a termination pursuant to Section 3(a)(iii), shall
be at least forty-five (45) days following the date of such notice (a “Notice of Termination”); provided
that the Company may, in its sole discretion, instruct Executive to remain off the Company’s premises and perform no
Company functions from the date of such Notice of Termination through the Date of Termination, but only to the extent that the
Company pays Executive full compensation and benefits during such period. The failure by the Company or Executive to set forth
in the Notice of Termination any fact or circumstance which contributes to a showing of Cause or Good Reason shall not waive any
right of such Party hereunder or preclude such Party from asserting such fact or circumstance in enforcing such Party’s
rights hereunder.

 

    	 	3	 

     

    

 

(c)          Company
Obligations upon Termination. Upon termination of Executive’s employment pursuant to any of the circumstances listed
in Section 3, Executive (or Executive’s estate) shall be entitled to receive the sum of: (i) the portion of
Executive’s Annual Base Salary earned through the Date of Termination, but not yet paid to Executive; (ii) any vacation
time that has been accrued but unused in accordance with the Company’s Policies; (iii) any reimbursements owed to Executive
pursuant to Section 2(f); and (iv) any amount accrued and arising from Executive’s participation in, or benefits
accrued under, any employee benefit plans, programs or arrangements, which amounts shall be payable in accordance with the terms
and conditions of such employee benefit plans, programs or arrangements (collectively, the “Company Arrangements”).
Except as otherwise expressly required by law (e.g., COBRA), as specifically provided herein, or with respect to any of
Executive’s equity-related compensation (which, for the avoidance of doubt, shall be governed by the terms and conditions
of the applicable equity compensation plans and agreements), all of Executive’s rights to salary, severance, benefits, bonuses
and other compensatory amounts hereunder (if any) shall cease upon the termination of Executive’s employment hereunder.
In the event that Executive’s employment is terminated by the Company for any reason, Executive’s sole and exclusive
remedy shall be to receive the payments and benefits described in this Section 3(c) and Section 4, as applicable.

 

(d)          Deemed
Resignation. Upon termination of Executive’s employment for any reason, Executive shall be deemed to have resigned from
all offices and directorships, if any, then held with the Company or any of its subsidiaries.

 

	4.	Severance Payments.

 

(a)          Termination
for Cause, or Termination Upon Death, Disability or Resignation from the Company Without Good Reason. If Executive’s
employment shall terminate as a result of Executive’s death pursuant to Section 3(a)(i) or Disability pursuant to
Section 3(a)(ii), pursuant to Section 3(a)(iii) for Cause, or pursuant to Section 3(a)(vi) for Executive’s
resignation from the Company without Good Reason, then Executive shall not be entitled to any severance payments or benefits,
except as provided in Section 3(c).

 

(b)          Termination
without Cause or Resignation for Good Reason. If Executive’s employment terminates without
Cause pursuant to Section 3(a)(iv), or pursuant to Section 3(a)(v) due to Executive’s resignation for
Good Reason, then, subject to Executive signing on or before the 21st day following the Date of Termination, and not
revoking during any subsequent revocation period contained therein, a release of claims substantially in the form attached as
Exhibit A to this Agreement (the “Release”), and Executive’s continued compliance with Sections
6 and 7, Executive shall receive, in addition to payments and benefits set forth in Section 3(c), the following:

 

(i)           an
amount in cash equal to 1.0 times the sum of (A) Annual Base Salary (at the highest level in effect during the Term) plus
(B) the average Annual Bonus over the prior three years or such shorter period as Executive has been employed by the Company
(provided that, if Executive has not yet received an Annual Bonus or an Annual Bonus with respect to a full year of employment
under the Company’s annual incentive program on the Date of Termination, such amount will be equal to the Target Bonus),
payable in the form of salary continuation in regular installments over the 12-month period following the Date of Termination
in accordance with the Company’s normal payroll practices;

 

    	 	4	 

     

    

 

(ii)          if
Executive timely elects continued medical, dental or vision coverage under one or more of the Company’s group medical, dental
or vision plans pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”),
then the Company shall directly pay, or reimburse Executive for, the COBRA premiums for Executive and Executive’s covered
dependents under such plans during the period commencing on the Date of Termination and ending 12-months following the Date of
Termination. Notwithstanding the foregoing, if the Company determines that it cannot provide the benefit required by this Section
4(b)(ii) without potentially violating applicable law (including Section 2716 of the Public Health Service Act) or incurring
an excise tax, the Company shall in lieu thereof provide to Executive a monthly payment in an after-tax amount equal to the monthly
COBRA premium that Executive would be required to pay to continue Executive’s and Executive’s covered dependents’
group health coverage in effect on the Date of Termination, which amount shall be based on the premium for the first month of
COBRA coverage; and

 

(iii)         any
unvested equity or equity-based awards granted to Executive under any of the Company’s equity incentive award plans or programs
that would have vested during the 12-month period following the Date of Termination shall become vested, provided that,
unless a provision more favorable to Executive is included in an applicable award agreement, any such awards that are subject
to performance-based vesting conditions (“Performance Equity Awards”) shall only be payable subject to the
attainment of the performance measures for the applicable performance period as provided under the terms of the applicable award
agreement.

 

(c)          Change
in Control. If Executive’s employment terminates without Cause pursuant to Section 3(a)(iv), or pursuant to Section
3(a)(v) due to Executive’s resignation for Good Reason, in either case, within one year following the date of a Change
in Control, then, subject to Executive signing on or before the 21st day following the Date of Termination, and not
revoking during any subsequent revocation period contained therein, the Release, and Executive’s continued compliance with
Sections 6 and 7, Executive shall receive, in addition to payments and benefits set forth in Section 3(c),
the following in lieu of the severance payments and benefits set forth in Section 4(b):

 

(i)           an
amount in cash equal to 2.0 times the sum of (A) Annual Base Salary (at the highest level in effect during the Term) plus
(B) the average Annual Bonus over the prior three years or such shorter period as Executive has been employed by the Company
(provided that, if Executive has not yet received an Annual Bonus or an Annual Bonus with respect to a full year of employment
under the Company’s annual incentive program on the Date of Termination, such amount will be equal to the Target Bonus),
payable in the form of salary continuation in regular installments over the 24-month period following the Date of Termination
in accordance with the Company’s normal payroll practices;

 

(ii)          if
Executive timely elects continued medical, dental or vision coverage under one or more of the Company’s or its successor’s
group medical, dental or vision plans pursuant to COBRA, then the Company shall directly pay, or reimburse Executive for, the
COBRA premiums for Executive and Executive’s covered dependents under such plans during the period commencing on the Date
of Termination and ending 24-months following the Date of Termination. Notwithstanding the foregoing, if the Company determines
that it cannot provide the benefit required by this Section 4(c)(ii) without potentially violating applicable law (including
Section 2716 of the Public Health Service Act) or incurring an excise tax, the Company shall in lieu thereof provide to Executive
a monthly payment in an after-tax amount equal to the monthly COBRA premium that Executive would be required to pay to continue
Executive’s and Executive’s covered dependents’ group health coverage in effect on the Date of Termination,
which amount shall be based on the premium for the first month of COBRA coverage; and

 

    	 	5	 

     

    

 

(iii)         all
unvested equity or equity-based awards granted to Executive under any of the Company’s equity incentive award plans or programs
shall immediately become 100% vested, provided that, with respect to any Performance Equity Award, vesting of such award
may remain subject to attaining applicable performance goals to the extent the relevant performance goals (which performance goals
shall be reviewed and may be adjusted by the Board (as constituted prior to the Change in Control) as applicable to reflect the
Change in Control transaction) continue to apply following the Change in Control. 

 

(d)          Survival.
Notwithstanding anything to the contrary in this Agreement, the provisions of Sections 4 through 10 and Section
12 will survive the termination of Executive’s employment and the expiration or termination of the Term.

 

	5.	Parachute Payments.

 

(a)          It
is the objective of this Agreement to maximize Executive’s Net After-Tax Benefit (as defined herein) if payments or benefits
provided under this Agreement are subject to excise tax under Section 4999 of the Internal Revenue Code of 1986, as amended, and
the regulations and guidance promulgated thereunder (the “Code”). Notwithstanding any other provisions of this
Agreement, in the event that any payment or benefit by the Company or otherwise to or for the benefit of Executive, whether paid
or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise (all such payments and benefits,
including the payments and benefits under Section 4(b) and Section 4(c) hereof, being hereinafter referred to as
the “Total Payments”), would be subject (in whole or in part) to the excise tax imposed by Section 4999
of the Code (the “Excise Tax”), then the Total Payments shall be reduced to the extent necessary so that no
portion of the Total Payments shall be subject to the Excise Tax, but only if (i) the net amount of such Total Payments, as so
reduced (and after subtracting the net amount of federal, state and local income and employment taxes on such reduced Total Payments
and after taking into account the phase out of itemized deductions and personal exemptions attributable to such reduced Total
Payments), is greater than or equal to (ii) the net amount of such Total Payments without such reduction (but after subtracting
the net amount of federal, state and local income and employment taxes on such Total Payments and the amount of Excise Tax to
which Executive would be subject in respect of such unreduced Total Payments and after taking into account the phase out of itemized
deductions and personal exemptions attributable to such unreduced Total Payments).

 

(b)          The
Total Payments shall be reduced by the Company in the following order: (i) reduction of any cash severance payments otherwise
payable to Executive that are exempt from Section 409A of the Code (“Section 409A”), (ii) reduction of
any other cash payments or benefits otherwise payable to Executive that are exempt from Section 409A, but excluding any payments
attributable to the acceleration of vesting or payments with respect to any equity award with respect to the Company’s common
stock that is exempt from Section 409A, (iii) reduction of any other payments or benefits otherwise payable to Executive on a
pro-rata basis or such other manner that complies with Section 409A, but excluding any payments attributable to the acceleration
of vesting and payments with respect to any equity award with respect to the Company’s common stock that are exempt from
Section 409A, and (iv) reduction of any payments attributable to the acceleration of vesting or payments with respect
to any other equity award with respect to the Company’s common stock that are exempt from Section 409A.

 

    	 	6	 

     

    

 

(c)          All
determinations regarding the application of this Section 5 shall be made by an accounting firm with experience in performing
calculations regarding the applicability of Section 280G of the Code and the Excise Tax selected by the Company and acceptable
to Executive (“Independent Advisors”), a copy of which report and all worksheets and background materials relating
thereto shall be provided to Executive. For purposes of determining whether and the extent to which the Total Payments will be
subject to the Excise Tax, (i) no portion of the Total Payments the receipt or enjoyment of which Executive shall have waived
at such time and in such manner as not to constitute a “payment” within the meaning of Section 280G(b) of the Code
shall be taken into account; (ii) no portion of the Total Payments shall be taken into account which, in the opinion of the Independent
Advisors, does not constitute a “parachute payment” within the meaning of Section 280G(b)(2) of the Code (including
by reason of Section 280G(b)(4)(A) of the Code) and, in calculating the Excise Tax, no portion of such Total Payments shall be
taken into account which, in the opinion of Independent Advisors, constitutes reasonable compensation for services actually rendered,
within the meaning of Section 280G(b)(4)(B) of the Code, in excess of the “base amount” (as defined in Section 280G(b)(3)
of the Code) allocable to such reasonable compensation; and (iii) the value of any non-cash benefit or any deferred payment or
benefit included in the Total Payments shall be determined by the Independent Advisors in accordance with the principles of Sections
280G(d)(3) and (4) of the Code. The costs of obtaining such determination and all related fees and expenses (including related
fees and expenses incurred in any later audit) shall be borne solely by the Company.

 

6.          Competition;
Non-disparagement. Executive acknowledges that Executive has been provided with Confidential
Information (as defined below) and, during the Term, the Company from time to time will provide Executive with access to Confidential
Information. Ancillary to the rights provided to Executive as set forth in this Agreement and the Company’s provision of
Confidential Information, and Executive’s agreements regarding the use of same, in order to protect the value of any Confidential
Information, the Company and Executive agree to the following provisions against unfair competition, which Executive acknowledges
represent a fair balance of the Company’s rights to protect its business and Executive’s right to pursue employment:

 

(a)          Executive
shall not, at any time during the Restriction Period (as defined below), directly or indirectly engage in, have any equity interest
in, interview for a potential employment or consulting relationship with or manage, provide services to or operate any person,
firm, corporation, partnership or business (whether as director, officer, employee, agent, representative, partner, security holder,
consultant or otherwise) that engages in any business which directly competes with any portion of the Business (as defined below)
anywhere in the world. Nothing herein shall prevent Executive from engaging in any activity with a non-competitive division of
an entity engaged in a business that competes with the Company; provided that none of Executive’s activities in respect
of such non-competitive division would reasonably be expected to cause Executive to otherwise breach his obligations under this
Section 6 in respect of the entity engaged in a business that competes with the Company. In addition, nothing herein shall
prohibit Executive from being a passive owner of not more than 5% of the outstanding equity interest in any entity that is publicly
traded, so long as Executive has no active participation in the business of such entity.

 

(b)          Except
in furtherance of his duties hereunder during the Term, Executive shall not, at any time during the Restriction Period, directly
or indirectly, (i) solicit any customers, clients or suppliers of the Company or (ii) solicit, with respect to hiring, any employee
or independent contractor of the Company or any person employed or engaged by the Company at any time during the 12-month period
immediately preceding the Date of Termination.

 

(c)          In
the event the terms of this Section 6 shall be determined by any court of competent jurisdiction to be unenforceable by
reason of its extending for too great a period of time or over too great a geographical area or by reason of its being too extensive
in any other respect, it will be interpreted to extend only over the maximum period of time for which it may be enforceable, over
the maximum geographical area as to which it may be enforceable, or to the maximum extent in all other respects as to which it
may be enforceable, all as determined by such court in such action.

 

    	 	7	 

     

    

 

(d)          As
used in this Section 6, (i) the term “Company” shall include the Company and its direct and indirect
subsidiaries; (ii) the term “Business” shall mean the business of the Company, as such business is conducted
as of the Effective Date or may be expanded or altered by the Company during the Term, in any case that represents more than 10%
of the Company’s gross annual revenues, and shall include any type of marine-based expeditions; and (iii) the term “Restriction
Period” shall mean the period beginning on the Effective Date and ending on the date 24 months following the Date of
Termination.

 

(e)          Each
Party to this Agreement (which, in the case of the Company, shall include its officers and the members of the Board) agrees, during
the Term and thereafter, to refrain from Disparaging (as defined below) the other Party and its affiliates. Nothing in this paragraph
shall preclude any Party from making truthful statements that are reasonably necessary to comply with applicable law, regulation
or legal process, or to defend or enforce a Party’s rights under this Agreement. For purposes of this Agreement, “Disparaging”
means making remarks, comments or statements, whether written or oral, that impugn the character, integrity, reputation or abilities
of the person or entity being disparaged.

 

	7.	Nondisclosure of Proprietary Information.

 

(a)          Except
in connection with the faithful performance of Executive’s duties hereunder or pursuant to Section 7(c) or (e), Executive
shall, in perpetuity, maintain in confidence and shall not directly, indirectly or otherwise, use, disseminate, disclose or publish,
or use for Executive’s benefit or the benefit of any person, firm, corporation or other entity (other than the Company)
any confidential or proprietary information or trade secrets of or relating to the Company (including business plans, business
strategies and methods, acquisition targets, intellectual property in the form of patents, trademarks and copyrights and applications
therefor, ideas, inventions, works, discoveries, improvements, information, documents, formulae, practices, processes, methods,
developments, source code, modifications, technology, techniques, data, programs, other know-how or materials, owned, developed
or possessed by the Company, whether in tangible or intangible form, information with respect to the Company’s operations,
processes, products, inventions, business practices, finances, principals, vendors, suppliers, customers, potential customers,
marketing methods, costs, prices, contractual relationships, regulatory status, prospects and compensation paid to employees or
other terms of employment) (collectively, the “Confidential Information”), or deliver to any person, firm,
corporation or other entity any document, record, notebook, computer program or similar repository of or containing any such Confidential
Information. The Parties hereby stipulate and agree that, as between them, any item of Confidential Information is important,
material and confidential and affects the successful conduct of the businesses of the Company (and any successor or assignee of
the Company). Notwithstanding the foregoing, Confidential Information shall not include any information that has been published
in a form generally available to the public or is publicly available or has become public knowledge prior to the date Executive
proposes to disclose or use such information, provided that such publishing or public availability or knowledge of the
Confidential Information shall not have resulted from Executive directly or indirectly breaching Executive’s obligations
under this Section 7(a) or any other similar provision by which Executive is bound, or from any third-party known by Executive
to be breaching a provision similar to that found under this Section 7(a). For the purposes of the previous sentence, Confidential
Information will not be deemed to have been published or otherwise disclosed merely because individual portions of the information
have been separately published, but only if material features comprising such information have been published or become publicly
available.

 

(b)          Upon
termination of Executive’s employment with the Company for any reason, Executive will promptly deliver to the Company all
correspondence, drawings, manuals, letters, notes, notebooks, reports, programs, plans, proposals, financial documents, or any
other documents or property concerning the Company’s customers, business plans, marketing strategies, products, property
or processes, provided that Executive may retain his compensation-related information, personal journal and rolodex, address
book, appointment book, calendar and/or contact list.

 

    	 	8	 

     

    

 

(c)          Notwithstanding
Section 7(a), Executive may respond to a lawful and valid subpoena or other legal process but shall give the Company the
earliest practicable notice thereof, shall, as much in advance of the return date as practicable, make available to the Company
and its counsel the documents and other information sought and shall assist such counsel at Company’s sole expense in resisting
or otherwise responding to such process, in each case to the extent permitted by applicable laws or rules.

 

(d)          As
used in this Section 7 and Section 8, the term “Company” shall include the Company and its direct
and indirect subsidiaries.

 

(e)          Nothing
in this Agreement shall prohibit Executive from (i) disclosing information and documents when required by law, subpoena or court
order (subject to the requirements of Section 7(c) above), (ii) disclosing information and documents to Executive’s
attorney, financial or tax adviser for the purpose of securing legal, financial or tax advice, (iii) disclosing Executive’s
post-employment restrictions in this Agreement in confidence to any potential new employer, or (iv) retaining, at any time, Executive’s
personal correspondence, Executive’s personal contacts and documents related to Executive’s own personal benefits,
entitlements and obligations.

 

	8.	Inventions.

 

All
rights to discoveries, inventions, improvements and innovations (including all data and records pertaining thereto) related to
the business of the Company, whether or not patentable, copyrightable, registrable as a trademark, or reduced to writing, that
Executive may discover, invent or originate during Executive’s period of service with the Company or its subsidiaries or
its or their predecessors, either alone or with others and whether or not during working hours or by the use of the facilities
of the Company (“Inventions”), shall be the exclusive property of the Company. Executive shall promptly disclose
all Inventions to the Company, shall execute at the request of the Company any assignments or other documents the Company may
deem reasonably necessary to protect or perfect its rights therein, and shall assist the Company, upon reasonable request and
in all instances at the Company’s sole expense, in obtaining, defending and enforcing the Company’s rights therein.
Executive hereby appoints the Company as Executive’s attorney-in-fact to execute on Executive’s behalf any assignments
or other documents reasonably deemed necessary by the Company to protect or perfect its rights to any Inventions.

 

	9.	Injunctive Relief.

 

It
is recognized and acknowledged by Executive that a breach of the covenants contained in Sections 6, 7 and 8 could cause
irreparable damage to Company and its goodwill, the exact amount of which may be difficult or impossible to ascertain, and that
the remedies at law for any such breach may be inadequate. Accordingly, Executive agrees that in the event of a breach of any
of the covenants contained in Sections 6, 7 and 8, in addition to any other remedy which may be available at law or in
equity, the Company will be entitled to seek specific performance and injunctive relief without the requirement to post bond.

 

    	 	9	 

     

    

 

	10.	Assignment and Successors.

 

None
of the Company’s rights or obligations may be assigned or transferred by the Company, except that the Company shall assign
its rights and obligations under this Agreement to any successor to all or substantially all of the business or the assets of
the Company (by merger or otherwise). This Agreement shall be binding upon and inure to the benefit of the Company, Executive
and their respective successors, assigns, legal representatives, executors, administrators, heirs, distributees, devisees, and
legatees, as applicable. None of Executive’s rights or obligations may be assigned or transferred by Executive, other than
Executive’s rights to payments hereunder, which may be transferred only by will or operation of law. Notwithstanding the
foregoing, Executive shall be entitled, to the extent permitted under applicable law and applicable Company Arrangements, to select
and change a beneficiary or beneficiaries to receive compensation hereunder following Executive’s death by giving written
notice thereof to the Company.

 

	11.	Certain Definitions.

 

(a)          Cause.
The Company shall have “Cause” to terminate Executive’s employment hereunder upon Executive’s:

 

(i)           willful
misconduct and mismanagement by Executive that is materially injurious to the Company;

 

(ii)          refusal
in any material respect to carry out or comply with any lawful and reasonable written directive of the Board consistent with the
terms of this Agreement;

 

(iii)         conviction,
plea of no contest, or plea of nolo contendere for any felony;

 

(iv)         unlawful
use (including being under the influence) or possession of illegal drugs on the Company’s (or any of its subsidiaries’)
premises while performing Executive’s duties and responsibilities under this Agreement;

 

(v)          commission
of an act of fraud, embezzlement, willful misappropriation, willful misconduct, or breach of fiduciary duty, in any case that
results in material harm to the Company or any of its affiliates;

 

(vi)          material
violation of any provision of this Agreement or a material Policy; or

 

(vii)         willful
or prolonged, and unexcused, absence from work (other than by reason of Executive’s Disability).

 

For
purposes of this definition, an action or inaction is only “willful” if it is done or omitted by Executive without
a good faith belief that such action or inaction is in the best interests of the Company.

 

Notwithstanding
the foregoing, no termination for Cause will have occurred unless and until the Company has: (a) provided Executive, within thirty
(30) days of the Company first becoming aware of the facts or circumstances constituting Cause, written-notice stating with specificity
the applicable facts and circumstances underlying such finding of Cause; and (b) provided Executive with an opportunity to
cure the same within thirty (30) days after the receipt of such notice. Any termination for Cause must occur within ninety (90)
days of the Company first becoming aware of the facts or circumstances constituting Cause.

 

(b)          Change
in Control. “Change in Control” shall have the meaning set forth in the version of the Company’s
2015 Long-Term Incentive Plan in effect on the Effective Date. 

 

    	 	10	 

     

    

 

(c)          Date
of Termination. “Date of Termination” shall mean (i) if Executive’s employment is terminated by Executive’s
death, the date of Executive’s death; and (ii) if Executive’s employment is terminated pursuant to Section 3(a)(ii)
– (vi), the date indicated in the Notice of Termination.

 

(d)          Disability.
“Disability” shall mean Executive’s inability to perform, with or without reasonable accommodation, the
essential functions of Executive’s position hereunder for a total of one hundred and eighty (180) days during any three
hundred and sixty five (365) day period as a result of incapacity due to mental or physical illness as determined by a physician
selected by the Company or its insurers, and acceptable to Executive or Executive’s legal representative, with such agreement
as to acceptability not to be unreasonably withheld, delayed or conditioned. Any refusal by Executive to submit to a reasonable
medical examination at the Company’s sole expense for the purpose of determining Disability shall be deemed to constitute
conclusive evidence of Executive’s Disability.

 

(e)          Good
Reason. Executive’s resignation will be for “Good Reason” if Executive resigns following the occurrence
of any of the following events: (i) a decrease in Executive’s Annual Base Salary (from the highest level in effect
during the Term); (ii) a material diminution in Executive’s authority, duties or responsibilities; (iii) a requirement
that Executive report to other than the Chief Executive Officer of the Company and the Board; (iv) a relocation of the location
at which Executive is required primarily to perform his services for the Company outside the Borough of Manhattan within the City
of New York; or (v) any other action or inaction that constitutes a material breach by the Company of this Agreement. Notwithstanding
the foregoing, no Good Reason will have occurred unless and until Executive has: (a) provided the Company, within ninety (90)
days of Executive’s first knowledge of the occurrence of the facts and circumstances underlying the Good Reason event, written-notice
stating with specificity the applicable facts and circumstances underlying such finding of Good Reason; and (b) provided
the Company with an opportunity to cure the same within thirty (30) days after the receipt of such notice.

 

	12.	Miscellaneous Provisions.

 

(a)          Governing
Law. This Agreement shall be governed, construed, interpreted and enforced in accordance with its express terms, and otherwise
in accordance with the substantive laws of the State of New York without reference to the principles of conflicts of law of the
State of New York or any other jurisdiction, and where applicable, the laws of the United States. Any suit brought hereon shall
be brought in the state or federal courts sitting in the Borough of Manhattan within the City of New York, the Parties hereby
waiving any claim or defense that such forum is not convenient or proper. Each Party hereby agrees that any such court shall have
in personam jurisdiction over it and consents to service of process in any manner authorized by New York law.

 

(b)          Validity.
The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability
of any other provision of this Agreement, which shall remain in full force and effect.

 

(c)          Notices.
Any notice, request, claim, demand, document and other communication hereunder to any Party shall be effective upon receipt (or
refusal of receipt) and shall be in writing and delivered personally or sent by facsimile or certified or registered mail, postage
prepaid, as follows:

 

		(i)	If
                                         to the Company, the Chief Executive Officer or the General Counsel at its headquarters,

 

and
copies to:

 

Latham
& Watkins LLP

555
Eleventh Street, N.W.

Washington,
DC 20004

Attention:
Paul Sheridan and Adam Kestenbaum

 

    	 	11	 

     

    

 

(ii)          If
to Executive, at the last address that the Company has in its personnel records for Executive.

 

(iii)         At
any other address as any Party shall have specified by notice in writing to the other Party.

 

(d)          Counterparts.
This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, but all of which together
will constitute one and the same Agreement. Signatures delivered by facsimile or email shall be deemed effective for all purposes.

 

(e)          Entire
Agreement. The terms of this Agreement are intended by the Parties to be the final expression of their agreement with respect
to the subject matter hereof and supersede all prior understandings and agreements, whether written or oral. The Parties further
intend that this Agreement shall constitute the complete and exclusive statement of their terms and that no extrinsic evidence
whatsoever may be introduced in any judicial, administrative, or other legal proceeding to vary the terms of this Agreement.

 

(f)          Certain
Indemnity Rights; D&O Coverage. During and after the Term, the Company shall (i) provide Executive with directors’
and officers’ liability insurance coverage at least as favorable as that applicable to any then-current chief executive
officer of the Company, and (ii) indemnify Executive and his legal representatives to the fullest extent permitted by the
laws of the State of Delaware against all damages, costs, expenses and other liabilities reasonably incurred or sustained by Executive
or his legal representatives in connection with any suit, action or proceeding to which Executive or his legal representatives
may be made a party by reason of Executive being or having been a director or officer of the Company or any of its subsidiaries,
or having served in any other capacity or taken any other action purportedly on behalf of or at the request of the Company or
any of its subsidiaries.

 

(g)          Amendments;
Waivers. This Agreement may not be modified, amended, or terminated except by an instrument in writing, signed by Executive
and a duly authorized representative of the Company. By an instrument in writing similarly executed, Executive or a duly authorized
representative of the Company may waive compliance by the other Party with any specifically identified provision of this Agreement
that such other Party was or is obligated to comply with or perform; provided that such waiver shall not operate as a waiver
of, or estoppel with respect to, any other or subsequent failure. No failure to exercise and no delay in exercising any right,
remedy, or power hereunder shall preclude any other or further exercise of any other right, remedy, or power provided herein or
by law or in equity.

 

(h)          No
Inconsistent Actions. The Parties hereto shall not voluntarily undertake or fail to undertake any action or course of action
inconsistent with the provisions or essential intent of this Agreement. Furthermore, it is the intent of the Parties hereto to
act in a fair and reasonable manner with respect to the interpretation and application of the provisions of this Agreement.

 

(i)          Construction.
This Agreement shall be deemed drafted equally by both Parties. Its language shall be construed as a whole and according to its
fair meaning. Any presumption or principle that the language is to be construed against any Party shall not apply. The headings
in this Agreement are only for convenience and are not intended to affect construction or interpretation. Any references to paragraphs,
subparagraphs, sections or subsections are to those parts of this Agreement, unless the context clearly indicates to the contrary.
Also, unless the context clearly indicates to the contrary, (a) the plural includes the singular and the singular includes the
plural; (b) “any,” “all,” “each,” or “every” means “any and all,”
and “each and every”; (c) “includes” and “including” are each “without limitation”;
(d) “herein,” “hereof,” “hereunder” and other similar compounds of the word “here”
refer to the entire Agreement and not to any particular paragraph, subparagraph, section or subsection; and (e) all pronouns and
any variations thereof shall be deemed to refer to the masculine, feminine, neuter, singular or plural as the identity of the
entities or persons referred to may require.

 

    	 	12	 

     

    

 

(j)          Arbitration.
Any controversy, claim or dispute arising out of or relating to this Agreement shall be settled solely and exclusively by a binding
arbitration process administered by JAMS/Endispute in New York, New York. Such arbitration shall be conducted in accordance with
the then-existing JAMS/Endispute Rules of Practice and Procedure, with the following exceptions if in conflict: (a) one arbitrator
who is a retired judge shall be chosen by JAMS/Endispute; (b) the Company will pay the expenses and fees of the arbitrator, together
with other expenses of the arbitration incurred or approved by the arbitrator; and (c) arbitration may proceed in the absence
of any Party if written notice (pursuant to the JAMS/Endispute rules and regulations) of the proceedings has been given to such
Party. Each Party shall bear its own attorney’s fees and expenses. The arbitrator may assess the prevailing Party’s
fees and costs against the non-prevailing Party as part of the arbitrator’s award and shall in all events award Executive
his reasonable fees and costs (including the reasonable fees and expenses of his counsel) if Executive prevails on one or more
substantive issues in the arbitration. The Parties agree to abide by all decisions and awards rendered in such proceedings. Such
decisions and awards rendered by the arbitrator shall be final and conclusive. All such controversies, claims or disputes shall
be settled in this manner in lieu of any action at law or equity; provided that nothing in this subsection shall be construed
as precluding the bringing an action for injunctive relief or specific performance as provided in this Agreement. This dispute
resolution process and any arbitration hereunder shall be confidential and neither any Party nor the neutral arbitrator shall
disclose the existence, contents or results of such process without the prior written consent of all Parties, except where necessary
or compelled in a court to enforce this arbitration provision or an award from such arbitration or otherwise in a legal proceeding.
If JAMS/Endispute no longer exists or is otherwise unavailable, the Parties agree that the American Arbitration Association (“AAA”)
shall administer the arbitration in accordance with its then-existing rules as modified by this subsection. In such event, all
references herein to JAMS/Endispute shall mean AAA. Notwithstanding the foregoing, Executive and the Company each have the right
to resolve any issue or dispute over intellectual property rights by court action instead of arbitration.

 

(k)          Enforcement.
If any provision of this Agreement is held to be illegal, invalid or unenforceable under present or future laws effective during
the Term, such provision shall be fully severable; this Agreement shall be construed and enforced as if such illegal, invalid
or unenforceable provision had never comprised a portion of this Agreement; and the remaining provisions of this Agreement shall
remain in full force and effect and shall not be affected by the illegal, invalid or unenforceable provision or by its severance
from this Agreement. Furthermore, in lieu of such illegal, invalid or unenforceable provision there shall be added automatically
as part of this Agreement a provision as similar in terms to such illegal, invalid or unenforceable provision as may be possible
and be legal, valid and enforceable, provided that the economic benefit to any Party is not diminished by such replacement.

 

(l)          Withholding.
The Company shall be entitled to withhold from any amounts payable under this Agreement any federal, state, local or foreign withholding
or other taxes or charges which the Company is required to withhold.

 

    	 	13	 

     

    

 

	 	(m)	Section 409A.

 

(i)          General.
The intent of the Parties is that the payments and benefits under this Agreement comply with or be exempt from Section 409A
and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith.

 

(ii)          Separation
from Service. Notwithstanding anything in this Agreement to the contrary, any compensation or benefits payable under this
Agreement that is considered nonqualified deferred compensation under Section 409A and is designated under this Agreement as payable
upon Executive’s termination of employment shall be payable only upon Executive’s “separation from service”
with the Company within the meaning of Section 409A (a “Separation from Service”) and, except as provided below,
any such compensation or benefits described in Section 4(b) and Section 4(c) shall not be paid, or, in the case
of installments, shall not commence payment, until the thirtieth (30th) day following Executive’s Separation from Service
(the “First Payment Date”). Any installment payments that would have been made to Executive during the thirty
(30) day period immediately following Executive’s Separation from Service but for the preceding sentence shall be paid to
Executive on the First Payment Date and the remaining payments shall be made as provided in this Agreement.

 

(iii)          Specified
Employee. Notwithstanding anything in this Agreement to the contrary, if Executive is deemed by the Company at the time of
Executive’s Separation from Service to be a “specified employee” for purposes of Section 409A, to the extent
delayed commencement of any portion of the benefits to which Executive is entitled under this Agreement is required in order to
avoid a prohibited distribution under Section 409A, such portion of Executive’s benefits shall not be provided to Executive
prior to the earlier of (A) the expiration of the six-month period measured from the date of Executive’s Separation
from Service with the Company or (B) the date of Executive’s death. Upon the first business day following the expiration
of the applicable Section 409A delay period, all payments deferred pursuant to the preceding sentence shall be paid in a lump
sum to Executive (or Executive’s estate or beneficiaries), and any remaining payments due to Executive under this Agreement
shall be paid as otherwise provided herein.

 

(iv)          Expense
Reimbursements. To the extent that any reimbursements under this Agreement are subject to Section 409A, (A) any such reimbursements
payable to Executive shall be paid to Executive no later than December 31 of the year following the year in which the expense
was incurred, provided that Executive submits Executive’s reimbursement request promptly following the date the expense
is incurred, (B) the amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent
year, other than medical expenses referred to in Section 105(b) of the Code, and (C) Executive’s right to reimbursement
under this Agreement will not be subject to liquidation or exchange for another benefit.

 

(v)          Installments.
Executive’s right to receive any installment payments under this Agreement, including any salary continuation payments
that are payable on Company payroll dates, shall be treated as a right to receive a series of separate payments and, accordingly,
each such installment payment shall at all times be considered a separate and distinct payment as permitted under Section 409A.
Except as otherwise permitted under Section 409A, no payment hereunder shall be accelerated or deferred unless such acceleration
or deferral would not result in additional tax, interest or penalties pursuant to Section 409A.

 

    	 	14	 

     

    

 

	13.	Executive Acknowledgement.

 

Executive
acknowledges that Executive has read and understands this Agreement, is fully aware of its legal effect, has not acted in reliance
upon any representations or promises made by the Company other than those contained in writing herein, and has entered into this
Agreement freely based on Executive’s own judgment.

 

[Signature
Page Follows]

 

    	 	15	 

     

    

 

IN
WITNESS WHEREOF, the Parties have executed this Agreement on the date and year first above written.

 

	 	COMPANY
	 	 	 
	 	By:	/s/
    Sven-Olof Lindblad
	 	 	Sven-Olof
    Lindblad
	 	 	President
    and CEO
	 	 	 
	 	EXECUTIVE
	 	 	 
	 	By:	/s/
    John T. McClain
	 	 	John
    T. McClain

 

[Signature Page to Employment Agreement]

 

     

     

    

 

EXHIBIT
A

 

Separation
Agreement and Release

 

This
Separation Agreement and Release (this “Agreement”) is made by and between John T. McClain (“Executive”)
and Lindblad Expeditions Holdings, Inc. (the “Company”) (collectively, referred to as the “Parties”
or individually referred to as a “Party”). Capitalized terms used but not defined in this Agreement shall have
the meanings set forth in the Employment Agreement (as defined below).

 

WHEREAS,
the Parties have previously entered into that certain Employment Agreement, dated as of October 27, 2015 (the “Employment
Agreement”); and

 

WHEREAS,
in connection with Executive’s termination of employment with the Company effective ________, 20__, the Parties wish to
resolve any and all disputes, claims, complaints, grievances, charges, actions, petitions, and demands that Executive may have
against the Company and any of the Releasees, as defined below, including, but not limited to, any and all claims arising out
of or in any way related to Executive’s employment with or separation from the Company or its subsidiaries or affiliates,
but, for the avoidance of doubt, nothing herein will be deemed to release any rights or remedies in connection with (i) Executive’s
ownership of vested equity securities, (ii) Executive’s right to indemnification or directors’ and officers’
liability insurance pursuant to contract or applicable law or, (iii) Executive’s rights under this Agreement or under the
Employment Agreement that expressly survive by its terms ((i) through (iii), collectively, the “Retained Claims”).

 

NOW,
THEREFORE, in consideration of the severance payments and benefits described in Section 4(b) and Section 4(c) of the Employment
Agreement, which, pursuant to the Employment Agreement, are conditioned on Executive’s execution and non-revocation of this
Agreement, and in consideration of the mutual promises made herein, the Company and Executive hereby agree as follows:

 

1.           Severance
Payments; Salary and Benefits. The Company agrees to provide Executive with the severance payments and benefits described
in Section 4(b) or Section 4(c), as applicable, of the Employment Agreement, payable at the times set forth in, and subject to
the terms and conditions of, the Employment Agreement. In addition, to the extent not already paid, and subject to the terms and
conditions of the Employment Agreement, the Company shall pay or provide to Executive all other payments or benefits described
in Section 3(c) of the Employment Agreement, subject to and in accordance with the terms thereof.

 

2.           Release
of Claims. Executive agrees that, other than with respect to the Retained Claims, the foregoing consideration represents settlement
in full of all outstanding obligations owed to Executive by the Company, any of its direct or indirect subsidiaries and any of
their current and former officers, directors, equity holders, managers, employees, agents, investors, attorneys, shareholders,
administrators, benefit plans, plan administrators, insurers, trustees, divisions, and subsidiaries and predecessor and successor
corporations and assigns (collectively, the “Releasees”). Executive, on his own behalf and on behalf of any
of Executive’s heirs, family members, executors, agents, and assigns, other than with respect to the Retained Claims, hereby
and forever releases the Releasees from, and agrees not to sue concerning, or in any manner to institute, prosecute, or pursue,
any claim, complaint, charge, duty, obligation, or cause of action relating to any matters of any kind, whether presently known
or unknown, suspected or unsuspected, that Executive may possess against any of the Releasees arising from any omissions, acts,
facts, or damages that have occurred up until and including the date Executive signs this Agreement, including, without limitation:

 

(a)          any
and all claims relating to or arising from Executive’s employment or service relationship with the Company or any of its
direct or indirect subsidiaries and the termination of that relationship;

 

    	 	A-1	 

     

    

 

(b)          any
and all claims relating to, or arising from, Executive’s right to purchase, or actual purchase of any shares of stock or
other equity interests of the Company or any of its subsidiaries, including, without limitation, any claims for fraud, misrepresentation,
breach of fiduciary duty, breach of duty under applicable state corporate law, and securities fraud under any state or federal
law;

 

(c)          any
and all claims for wrongful discharge of employment; termination in violation of public policy; discrimination; harassment; retaliation;
breach of contract, both express and implied; breach of covenant of good faith and fair dealing, both express and implied; promissory
estoppel; negligent or intentional infliction of emotional distress; fraud; negligent or intentional misrepresentation; negligent
or intentional interference with contract or prospective economic advantage; unfair business practices; defamation; libel; slander;
negligence; personal injury; assault; battery; invasion of privacy; false imprisonment; conversion; and disability benefits;

 

(d)          any
and all claims for violation of any federal, state, or municipal statute, including, but not limited to, Title VII of the Civil
Rights Act of 1964; the Civil Rights Act of 1991; the Rehabilitation Act of 1973; the Americans with Disabilities Act of 1990;
the Equal Pay Act; the Fair Credit Reporting Act; the Age Discrimination in Employment Act of 1967; the Older Workers Benefit
Protection Act; the Employee Retirement Income Security Act of 1974; the Worker Adjustment and Retraining Notification Act; the
Family and Medical Leave Act; and the Sarbanes-Oxley Act of 2002;

 

(e)          any
and all claims for violation of the federal or any state constitution; and

 

(f)
          any and all claims arising out of any other laws and regulations relating to employment or employment discrimination.

 

Executive
agrees that the release set forth in this section shall be and remain in effect in all respects as a complete general release
as to the matters released. This release does not release claims that cannot be released as a matter of law, including, but not
limited to, Executive’s right to file a charge with or participate in a charge by the Equal Employment Opportunity Commission,
or any other local, state, or federal administrative body or government agency that is authorized to enforce or administer laws
related to employment, against the Company (with the understanding that Executive’s release of claims herein bars Executive
from recovering such monetary relief from the Company or any Releasee), claims for unemployment compensation or any state disability
insurance benefits pursuant to the terms of applicable state law, claims to continued participation in certain of the Company’s
group benefit plans pursuant to the terms and conditions of COBRA, claims to any benefit entitlements vested as the date of separation
of Executive’s employment, pursuant to written terms of any employee benefit plan of the Company or its affiliates and Executive’s
right under applicable law and any Retained Claims. This release further does not release claims for breach of Section 3(c), Section
4(b) or Section 4(c) of the Employment Agreement or any rights you may have in your capacity as an equityholder in the Company.

 

    	 	A-2	 

     

    

 

3.           Acknowledgment
of Waiver of Claims under ADEA. Executive understands and acknowledges that Executive is waiving and releasing any rights
Executive may have under the Age Discrimination in Employment Act of 1967 (the “ADEA”), and that this waiver
and release is knowing and voluntary. Executive understands and agrees that this waiver and release does not apply to any rights
or claims that may arise under the ADEA after the Effective Date of this Agreement. Executive understands and acknowledges that
the consideration given for this waiver and release is in addition to anything of value to which Executive was already entitled.
Executive further understands and acknowledges that Executive has been advised by this writing that: (a) Executive should consult
with an attorney prior to executing this Agreement; (b) Executive has 21 days within which to consider this Agreement; (c) Executive
has 7 days following Executive’s execution of this Agreement to revoke this Agreement pursuant to written notice to the
Chief Executive Officer or General Counsel of the Company; (d) this Agreement shall not be effective until after the revocation
period has expired; and (e) nothing in this Agreement prevents or precludes Executive from challenging or seeking a determination
in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties, or costs for
doing so, unless specifically authorized by federal law. In the event Executive signs this Agreement and returns it to the Company
in less than the 21 day period identified above, Executive hereby acknowledges that Executive has freely and voluntarily chosen
to waive the time period allotted for considering this Agreement.

 

4.           Severability.
In the event that any provision or any portion of any provision hereof or any surviving agreement made a part hereof becomes or
is declared by a court of competent jurisdiction or arbitrator to be illegal, unenforceable, or void, this Agreement shall continue
in full force and effect without said provision or portion of provision.

 

5.           No
Oral Modification. This Agreement may only be amended in a writing signed by Executive and a duly authorized officer of the
Company.

 

6.           Governing
Law; Notice; Counterparts; Dispute Resolution. This Agreement shall be subject to the provisions of Sections 12(a), (c), (d)
and (j) of the Employment Agreement.

 

7.          Effective
Date. If Executive has attained or is over the age of 40 as of the date of Executive’s termination of employment, then
Executive has seven days after Executive signs this Agreement to revoke it and this Agreement will become effective on the eighth
day after Executive signed this Agreement, so long as it has not been revoked by Executive before that date (the “Effective
Date”). If Executive has not attained the age of 40 as of the date of Executive’s termination of employment, then
the Effective Date shall be the date on which Executive signs this Agreement.

 

8.           Voluntary
Execution of Agreement. Executive understands and agrees that Executive executed this Agreement voluntarily, without any duress
or undue influence on the part or behalf of the Company or any third party, with the full intent of releasing all of Executive’s
claims against the Company and any of the other Releasees to the extent set forth in this Agreement. Executive acknowledges that:
(a) Executive has read this Agreement; (b) Executive has not relied upon any representations or statements made by the Company
that are not specifically set forth in this Agreement; (c) Executive has been represented in the preparation, negotiation, and
execution of this Agreement by legal counsel of his own choice or has elected not to retain legal counsel; (d) Executive understands
the terms and consequences of this Agreement and of the releases it contains; and (e) Executive is fully aware of the legal and
binding effect of this Agreement.          

 

[Signature
Page Follows]

 

    	 	A-3	 

     

    

 

IN
WITNESS WHEREOF, the Parties have executed this Agreement on the respective dates set forth below.

 

	 	EXECUTIVE
	 	 	 
	 	 	 
	Dated:
                              	John T. McClain
	 	 	 
	 	COMPANY
	 	 	 
	Dated:                           	By:
    	 
	 	Name:	 
	 	Title:	 

 

 

A-4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00250-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00250-of-00352.parquet"}]]